LISATA THERAPEUTICS, INC.: capex
| Value | {"amount": 506783, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-09-30 |
| Status | current |
| Entity | LISATA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:30:02.546101+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a2df9f8b-d984-4bf1-bfda-2f9ea65699da
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000320017-12-000019 · Open the official SEC filing →Retrieved: 2026-08-19T07:30:02.546101+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000320017/capex/2011-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a2df9f8b-d984-4bf1-bfda-2f9ea65699da
History
- supersedes {"amount": 5453931, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001144204-11-062961)